Vaddi Krishna - 31 Dec 2025 SCHEDULE 13G/A Report for Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD)

Filing Manager: Vaddi Krishna
Reporting Manager: Vaddi Krishna
Security: Prelude Therapeutics Inc Common Stock, par value $0.0001 per share
Symbol: PRLD
Shares outstanding: 51,297,696 shares
Disclosed Ownership: 6,745,647 shares
Ownership: 13%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2026, 16:02:12 UTC
Date of event: 31 Dec 2025
Previous filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vaddi Krishna	13%	6,745,647	6,745,647	0	/s/ Krishna Vaddi	Krishna Vaddi